Abstract:Shuang-Ge Liu, 1, * Xiao-Xiong Wu, 2, * Teng Hua, 1, * Xiao-Yan Xin, 1 Di-Lu Feng, 1 Shu-Qi Chi, 1 Xiao-Xiao Wang, 1 Hong-Bo Wang 1 1 Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China; 2 Department of Emergency, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China Correspondence: Hong-Bo Wang Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, People's Republic of China Tel +86 1 592 742 7529 Fax +86 278 572 6362 Email hb_wang1969@sina.com *These authors contributed equally to this work Background: Activation of NLPR3 inflammasome is associated with the development and progression of some types of malignant tumors, but its role in endometrial cancer is unclear. This study aimed to investigate the expression and function of NLRP3 inflammasome in endometrial cancer. Materials and methods: The expression levels of NLRP3, its inflammasome components and estrogen receptor β in endometrial cancer and paired non-tumor tissues were detected. The effects of NLPR3 silencing or overexpression on the proliferation, migration, and invasion of Ishikawa and HEC-1A cells were determined. The impact of NLPR3 silencing on the growth of implanted tumors was determined in vivo. The effects of estrogen on NLPR3 inflammasome activation and Ishikawa cell proliferation were determined. Results: The upregulation of NLRP3, ASC, caspase-1, and IL-1β was associated with the progression of endometrial cancer and poor survival. NLPR3 silencing inhibited the proliferation, migration, and invasion of endometrial cancer cells while NLPR3 overexpression had opposite effects. NLPR3 silencing reduced IL-1β and caspase-1 expression and the growth of implanted endometrial tumors, accompanied by decreased pro-IL-1β maturation. Estrogen enhanced NLPR3, ERβ, pro-IL-1β, IL-1β expression, and endometrial cancer cell proliferation, which were mitigated by treatment with ERβ inhibitor but not ERα inhibitor. Conclusion: Our results suggest that estrogen acts through ERβ to enhance the activation of NLPR3 inflammasome and promote the progression of endometrial cancer. NLPR3 inflammasome may be a new therapeutic target for endometrial cancer. Keywords: NLRP3, endometrial cancer, estrogen, inflammasome, ERβ

Nlrp3 Inflammasome Activation Of Mast Cells By Estrogen Via The Nuclear-Initiated Signaling Pathway Contributes To The Development Of Endometriosis

Role of Mast Cells in Estrogen-Mediated Experimental Endometriosis in Rats

Estrogen is an Important Mediator of Mast Cell Activation in Ovarian Endometriomas

Possible Involvement of Crosstalk Between Endometrial Cells and Mast Cells in the Development of Endometriosis Via CCL8/CCR1

GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain <i>via</i> the production of FGF2

P2X3 Receptor Involvement in Endometriosis Pain Via ERK Signaling Pathway.

Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion.

NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer

Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis Through CSF1R/JAK3/STAT6 Signaling

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

NLRP3 activated macrophages promote endometrial stromal cells migration in endometriosis

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response

NLRP3 inflammasome-mediated Pyroptosis induce Notch signal activation in endometriosis angiogenesis

Identification of NFASC and CHL1 As Two Novel Hub Genes in Endometriosis Using Integrated Bioinformatic Analysis and Experimental Verification.

Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications

Estrogen plays an important role by influencing the NLRP3 inflammasome

Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis

Role of the NLRP3 inflammasome in gynecological disease

TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis

Increasing expression of STING by ERα antagonizes LCN2 downregulation during chronic endometritis